SCHEMBL8642207

SCHEMBL8642207

Oc1ccc(/C(=C(/Cl)c2ccccc2)c2ccc(OCCCCCl)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 16/20 0.58
▸ ESR2 Q92731 11/20 0.58
▸ CYP19A1 P11511 9/20 0.58
▸ EBP Q15125 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ KCNH2 Q12809 2/20 0.58
▸ SIGMAR1 Q99720 2/20 0.58
▸ CHRM2 P08172 2/20 0.58
▸ ADRA2A P08913 2/20 0.58
▸ ADORA3 P0DMS8 2/20 0.58
▸ CHRM1 P11229 2/20 0.58
▸ PTGS1 P23219 2/20 0.58
▸ SLC6A2 P23975 2/20 0.58
▸ SLC6A4 P31645 2/20 0.58
▸ DRD3 P35462 2/20 0.58
▸ HTR6 P50406 2/20 0.58
▸ SLC6A3 Q01959 2/20 0.58
▸ KDM4E B2RXH2 2/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ PGR P06401 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8770194 1.00 ESR1 (0.58) ESR1ESR2CYP19A1EBPKMT2A
SCHEMBL8613926 0.94 ESR1 (0.63) ESR1ESR2CYP19A1EBPKMT2A
SCHEMBL8639615 0.94 ESR1 (0.63) ESR1ESR2CYP19A1EBPKMT2A
SCHEMBL8639612 0.94 ESR1 (0.63) ESR1ESR2CYP19A1EBPKMT2A
SCHEMBL8639618 0.94 ESR1 (0.63) ESR1ESR2CYP19A1EBPKMT2A
SCHEMBL8644016 0.93 ESR1 (0.62) ESR1ESR2CYP19A1EBPKMT2A
SCHEMBL8644018 0.93 ESR1 (0.62) ESR1ESR2CYP19A1EBPKMT2A
SCHEMBL8644014 0.93 ESR1 (0.62) ESR1ESR2CYP19A1EBPKMT2A
SCHEMBL8770160 0.89 ESR1 (0.55) ESR1ESR2CYP19A1EBPKMT2A
SCHEMBL17152214 0.86 CYP19A1 (0.81) ESR1ESR2CYP19A1EBPKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0720597-B1 TRIARYL-ETHYLENE DERIVATIVES FOR USE IN THERAPY MERRELL PHARMA INC (US) 1998-04-29 — — EP disclosed
EP-0794771-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1997-09-17 — — EP disclosed
EP-0720597-A1 TRIARYL-ETHYLENE DERIVATIVES FOR USE IN THERAPY MERRELL PHARMACEUTICALS INC. (US) 1996-07-10 — — EP disclosed
US-5525633-A ANTITUMOR AGENTS, ANTICHOLESTEROL AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1996-06-11 — — US disclosed
WO-1996016646-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1996-06-06 — — WO disclosed
WO-1995008528-A1 TRIARYL-ETHYLENE DERIVATIVES FOR USE IN THERAPY MERRELL PHARMACEUTICALS INC. (US) 1995-03-30 — — WO disclosed
Send feedback